News
Genetic Analysis AS launches AInsight for AI-assisted interpretation of GA-map® Dysbiosis Test results
OSLO, NORWAY – March 12: Genetic Analysis AS (“GA” or “the Company”) today announces the launch of GA-map® Dysbiosis Test…
Publication of year-end report 2025
OSLO, NORWAY – February 27, 2026: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the year-end report for 2025….
Genetic Analysis AS further strengthens IP portfolio with patent approval in the United States
OSLO, NORWAY – February 19, 2026: Genetic Analysis AS (“GA” or “the Company”) announces that its patent application US2017/0369941 has…
Microbiome Dx Genetic Analysis announces important patent approval enhancing the use of GA-map® in Canada
OSLO, NORWAY – February 12, 2026: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that its important…
Publication of interim report Q3 2025
OSLO, NORWAY – November 27, 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for Q3,…
Genetic Analysis AS announces milestone in the IBD diagnostic test development project – completion of biomarker panel for GA-map® IBD Precision Dx
OSLO, NORWAY – 17 November 2025: Microbiome DX company Genetic Analysis AS (“GA”) is pleased to announce the completion of…
Genetic Analysis attends the Biomarkers & Precision Medicine congress in London
OSLO, NORWAY, September 26, 2025: Microbiome DX company Genetic Analysis AS (“GA”) announces its attendance at the Biomarkers & Precision Medicine…
Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit
OSLO, NORWAY – 24 September 2025: Microbiome DX company Genetic Analysis AS (“GA”) announces the launch of a novel Research…
Publication of Half-year report 2025
OSLO, NORWAY – August 27 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the half-year report for H1,…
Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA
OSLO, NORWAY/IRVINE, CA, USA – 29 July 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Pangea Laboratory LLC (“Pangea”)…
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises
Genetic Analysis AS’ (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on June…
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises
OSLO, NORWAY – June 18, 2025: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that the…
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis AS: Mandatory notification of trade
OSLO, NORWAY – 12 June 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and…